You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORMP Disposition Disclosure
Kidron Nadav · SEC Form 4 · Filed Sep 25, 2026
Disposition
Reported value range
Not reported
Kidron Nadav President And CEO
ORMP
Transaction date
Sep 24, 2026
Public filing date
Sep 25, 2026
Filing lag
Filed 1 day later
ORMP daily price context
Close on/before transaction
$4.79
Sep 24, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock option (right to buy) on Common Stock
- Quantity / price
- 150,000 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001213900-26-103540
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oramed Pharmaceuticals Inc. ORMP | Award | Sep 24, 2026 | Not reported |
| Oramed Pharmaceuticals Inc. ORMP | Award | Sep 24, 2026 | Not reported |
| Oramed Pharmaceuticals Inc. ORMP | Disposition | Sep 24, 2026 | Not reported |
| Oramed Pharmaceuticals Inc. ORMP | Disposition | Sep 24, 2026 | Not reported |
| Oramed Pharmaceuticals Inc. ORMP | Disposition | Sep 24, 2026 | Not reported |
| Oramed Pharmaceuticals Inc. ORMP | Disposition | Sep 24, 2026 | Not reported |
| Oramed Pharmaceuticals Inc. ORMP Current | Disposition | Sep 24, 2026 | Not reported |
| Oramed Pharmaceuticals Inc. ORMP | Disposition | Sep 24, 2026 | Not reported |